PathwayReady™ MAP Kinase Signaling Inhibitor Panel

A convenient set consisting of seven inhibitors useful for the study of MAP Kinase signaling pathway. The seven inhibitors are: 1 mg of PD 184352 (Cat. No. 1585-1), 5 mg of PD 98059 (Cat. No. 1666-5), 1 mg of SB 203580 (Cat. No. 1712-1), 25 mg of Sorafenib (Cat. No. 1594-25), 5 mg of SP 600125 (Cat. No. 1669-5), 5 mg of U0126 (Cat. No. 1668-5), and 1 mg of ZM 336372 (Cat. No. 1789-1).

Alternate Name/Synonyms: MAP Kinase Signaling Inhibitor Panel, PathwayReady™

Appearance: Lyophilized solids

Appearance: N/A

Appearance: See under the individual product

Appearance: See under the individual product

Peptide sequence: N/A

Salt Form: No

Molecular Formula: See under the individual product

Molecular Weight: See under the individual product

Cell-Permeable?: Yes

Purity: ≥95% by HPLC

Solubilities: DMSO

Handling: Protect from air and light

Country of Origin: USA

Tag Line: A MAP kinase pathway inhibitors set

MDL Number: N/A

PubChem CID: N/A

SMILES: N/A

InChi: N/A

InChi Key: N/A

Category: Biochemicals